US Stock MarketDetailed Quotes

CVAC CureVac

Watchlist

3.240
-0.010-0.31%

Close Aug 16 16:00 ET

3.240
0.0000.00%

Post 20:01 ET

726.78MMarket Cap-2363P/E (TTM)

CureVac Stock Forum

Trytosaveabit

Aug 15 16:37

Update! Make a note for the date in last sentence! GSK has partnered in this! Good enough for GSK! I guess good enough for me? Hehehe

$CureVac (CVAC.US)$
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study
in Patients with Resected Glioblastoma

·First patient administered in dose-confirmation Part B of Phase 1 study with mRNA-based, multiepitope cancer vaccine candidate CVGBM
·Part B expected to include up to 20 patients to generate extended data on safety, tolerabil...

Mr 蓝波湾

Jul 16 21:42

Update on my holds

Share Your Profit/Loss

Trytosaveabit

Jul 11 12:52

Gettin a lil bita juice from that IMO bullish PR

$CureVac (CVAC.US)$ 🤫💸

Trytosaveabit

Jul 11 06:22

Update

$CureVac (CVAC.US)$ CureVac Announced The Latest Trial Dates For Its Ongoing Patent Litigation Against Pfizer/BioNTech In Multiple Geographies, Including The U.S., UK, And Germany
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...